Hydrops Fetalis Cases in a Saudi Tertiary Center: Etiologies and Outcomes, 2016-2022

Kamal Ali published a retrospective cohort study of 63,000 deliveries at a Saudi tertiary referral hospital from 2016 to 2022. The dataset includes 116 cases of non-immune hydrops fetalis and 14 cases of immune hydrops fetalis, detailing antenatal predictors, perinatal outcomes, and one-year survival rates. The data provides birth-prevalence benchmarks for a Middle East tertiary center.

Use Cases

• Predicting intrauterine fetal death or termination based on gestational age at diagnosis and presence of pleural effusion.
• Modeling one-year survival for live-born infants with non-immune hydrops based on gestational age at delivery.
• Comparing survival outcomes and resource use between immune and non-immune hydrops fetalis cases.
• Analyzing the prevalence and outcomes of hydrops fetalis in a Middle Eastern tertiary care setting.

Strengths

• Includes 63,000 deliveries over a seven-year period (2016–2022).
• Provides specific prevalence figures: 1.84/1,000 for NIHF and 0.22/1,000 for immune hydrops.
• Contains multivariable logistic regression results with adjusted odds ratios and confidence intervals for key predictors.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single center, which may limit generalizability.

Provenance

Source

figshare

Collection Method

Single-center retrospective cohort study.

Time Range

2016–2022

Freshness

Last updated 2026-05-04 05:32:56; freshness should be verified.

Geography

Saudi Arabia (tertiary referral hospital)